1071TiP Phase I study of the investigational CD228 x 4-1BB costimulatory antibody anticalin bispecific SGN-BB228 (PF-08046049) in advanced melanoma and other solid tumors.

Saved in:
Bibliographic Details
Title: 1071TiP Phase I study of the investigational CD228 x 4-1BB costimulatory antibody anticalin bispecific SGN-BB228 (PF-08046049) in advanced melanoma and other solid tumors.
Authors: Dummer, R.1 (AUTHOR), Daud, A.2 (AUTHOR), Eigentler, T.K.3 (AUTHOR), Evans, T.R.J.4 (AUTHOR), Henry, J.5 (AUTHOR), Hodi, F.S.6 (AUTHOR), Miller, W.H.7 (AUTHOR), Robert, C.8 (AUTHOR), Saibil, S.9 (AUTHOR), Tachiki, L.10 (AUTHOR), Nayeri, M.11 (AUTHOR), Xing, B.12 (AUTHOR), Mehnert, J.M.13 (AUTHOR)
Source: Annals of Oncology. 2024 Supplement 2, Vol. 35, pS709-S709. 1p.
Database: Academic Search Ultimate
Description
ISSN:09237534
DOI:10.1016/j.annonc.2024.08.1129